Versant Capital Management, Inc Repligen Corp Transaction History

Versant Capital Management, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 08, 2024	BUY	$114.17 - $185.35 $228 - $370	2 New	2 $0
Q4 2022 Jan 25, 2023	SELL	$162.42 - $220.56 $162 - $220	-1 Reduced 3.57%	27 $0
Q3 2022 Dec 30, 2022	BUY	$160.42 - $256.21 $160 - $256	1 Added 3.7%	28 $5,000
Q2 2022 Aug 02, 2022	BUY	$140.68 - $188.02 $3,235 - $4,324	23 Added 575.0%	27 $4,000
Q1 2021 Apr 27, 2021	BUY	$180.37 - $226.26 $721 - $905	4 New	4 $1,000

489

54.3M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.32B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Versant Capital Management, Inc with notifications on news.